Prevents healthcare entities from refusing to authorize, approve, or pay a provider.
For providing covered clinician-administered drugs, related services to covered person.
Would also prevent healthcare entities from imposing coverage or benefits limitations.
Alternatively, require enrollee to pay additional fee, higher copay, coinsurance, second copay, second coinsurance, other penalty when obtaining clinician-administered drugs.
Would prohibit interference with right to choose to obtain clinician-administered drug.
Legislative History
On Jan. 12, 2024, bill introduced in the Senate; on Mar. 7, 2024, bill passed in Senate.
On Mar. 8, 2024, bill introduced in the House; on Jun. 12, 2024, bill passed in House.
On Jun. 13, 2024, Senate passed in concurrence; on Jun. 24, 2024, bill was approved.
Effectiveness
This act, Ch. 223, 232, shall take effect on Jan. 1, 2025.
